Cerus gets multiple in-country approvals for INT200 illumination device

Cerus (CERS) Corporation announced two in-country regulatory approvals for INT200, its next-generation LED-based illumination device. The approvals were from the French National Agency for Medicines and Health Product Safety and the Swiss Agency for Therapeutic Products. These approvals follow the CE Mark authorization received in March. Cerus expects to convert its installed base of INT100s in EMEA to INT200s over the next three years and plans a PMA submission to the FDA during 2026.